PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TARS vs. AAPL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TARS and AAPL is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

TARS vs. AAPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tarsus Pharmaceuticals, Inc. (TARS) and Apple Inc (AAPL). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
55.70%
-0.43%
TARS
AAPL

Key characteristics

Sharpe Ratio

TARS:

1.71

AAPL:

1.17

Sortino Ratio

TARS:

2.46

AAPL:

1.76

Omega Ratio

TARS:

1.29

AAPL:

1.22

Calmar Ratio

TARS:

1.83

AAPL:

1.58

Martin Ratio

TARS:

5.73

AAPL:

4.09

Ulcer Index

TARS:

18.02%

AAPL:

6.43%

Daily Std Dev

TARS:

60.70%

AAPL:

22.62%

Max Drawdown

TARS:

-77.67%

AAPL:

-81.80%

Current Drawdown

TARS:

-21.12%

AAPL:

-9.94%

Fundamentals

Market Cap

TARS:

$2.11B

AAPL:

$3.51T

EPS

TARS:

-$3.75

AAPL:

$6.07

Total Revenue (TTM)

TARS:

$116.55M

AAPL:

$271.46B

Gross Profit (TTM)

TARS:

$108.65M

AAPL:

$125.83B

EBITDA (TTM)

TARS:

-$86.10M

AAPL:

$91.44B

Returns By Period

In the year-to-date period, TARS achieves a -19.94% return, which is significantly lower than AAPL's -6.84% return.


TARS

YTD

-19.94%

1M

-15.56%

6M

55.71%

1Y

100.59%

5Y*

N/A

10Y*

N/A

AAPL

YTD

-6.84%

1M

-5.98%

6M

-0.43%

1Y

26.09%

5Y*

25.12%

10Y*

25.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TARS vs. AAPL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TARS
The Risk-Adjusted Performance Rank of TARS is 8888
Overall Rank
The Sharpe Ratio Rank of TARS is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of TARS is 8888
Sortino Ratio Rank
The Omega Ratio Rank of TARS is 8585
Omega Ratio Rank
The Calmar Ratio Rank of TARS is 9090
Calmar Ratio Rank
The Martin Ratio Rank of TARS is 8585
Martin Ratio Rank

AAPL
The Risk-Adjusted Performance Rank of AAPL is 8282
Overall Rank
The Sharpe Ratio Rank of AAPL is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of AAPL is 7979
Sortino Ratio Rank
The Omega Ratio Rank of AAPL is 7777
Omega Ratio Rank
The Calmar Ratio Rank of AAPL is 8888
Calmar Ratio Rank
The Martin Ratio Rank of AAPL is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TARS vs. AAPL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TARS, currently valued at 1.71, compared to the broader market-2.000.002.001.711.17
The chart of Sortino ratio for TARS, currently valued at 2.46, compared to the broader market-4.00-2.000.002.004.002.461.76
The chart of Omega ratio for TARS, currently valued at 1.29, compared to the broader market0.501.001.502.001.291.22
The chart of Calmar ratio for TARS, currently valued at 1.83, compared to the broader market0.002.004.006.001.831.58
The chart of Martin ratio for TARS, currently valued at 5.73, compared to the broader market0.0010.0020.005.734.09
TARS
AAPL

The current TARS Sharpe Ratio is 1.71, which is higher than the AAPL Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of TARS and AAPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
1.71
1.17
TARS
AAPL

Dividends

TARS vs. AAPL - Dividend Comparison

TARS has not paid dividends to shareholders, while AAPL's dividend yield for the trailing twelve months is around 0.42%.


TTM20242023202220212020201920182017201620152014
TARS
Tarsus Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AAPL
Apple Inc
0.42%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%1.67%

Drawdowns

TARS vs. AAPL - Drawdown Comparison

The maximum TARS drawdown since its inception was -77.67%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for TARS and AAPL. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-21.12%
-9.94%
TARS
AAPL

Volatility

TARS vs. AAPL - Volatility Comparison

Tarsus Pharmaceuticals, Inc. (TARS) has a higher volatility of 15.21% compared to Apple Inc (AAPL) at 5.76%. This indicates that TARS's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
15.21%
5.76%
TARS
AAPL

Financials

TARS vs. AAPL - Financials Comparison

This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab